BT
BlossomHill Therapeutics, Inc.
SEC filingPharmaceuticals · San Diego, CA
Amount raised$84.2Msold at filing
Total offering$84.2M
Investors in the raise47count reported to the SEC
FiledDec 10, 2025first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
GEORGE LEEDirector
CARL GORDONDirector
YISHAN LIExecutive Officer, Director
SUNDEEP AGRAWALDirector
BIHUA CHENDirector
TIMOTHY STUBBSDirector
JINGRONG JEAN CUIExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.